Probi and Örebro University to collaborate on research into exploration of novel, needle free vaccines
Örebro University, in collaboration with Probi AB, and nine other Swedish companies have been granted funding for research into novel, needle free vaccines through delivery via mucous membranes instead of using traditional injections. Researchers will develop different types of novel vaccines and investigate vaccination through the mucous membranes. The delivery technology project will include the use of probiotic bacteria as carriers for the vaccine antigens, with the aim of inducing immunity against pathogens. The capability of probiotic bacteria to persist in close proximity to the